SCHEMBL9284669

SCHEMBL9284669

CCCCCc1nn(-c2ccncc2)c2ccccc12

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KHK P50053 3/20 0.48
▸ CNR2 P34972 3/20 0.41
▸ CNR1 P21554 1/20 0.41
▸ SLC6A2 P23975 1/20 0.40
▸ ALDH1A1 P00352 5/20 0.40
▸ LMNA P02545 3/20 0.40
▸ HTT P42858 3/20 0.40
▸ KDM4E B2RXH2 2/20 0.40
▸ USP2 O75604 2/20 0.40
▸ HPGD P15428 2/20 0.40
▸ TSHR P16473 2/20 0.40
▸ SMN1; SMN2 Q16637 2/20 0.40
▸ POLB P06746 1/20 0.40
▸ PKM P14618 1/20 0.40
▸ ALOX15 P16050 1/20 0.40
▸ ALOX12 P18054 1/20 0.40
▸ NPSR1 Q6W5P4 1/20 0.40
▸ TDP1 Q9NUW8 2/20 0.40
▸ L3MBTL1 Q9Y468 2/20 0.40
▸ ADRA1A P35348 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19501177 0.77 ADRA1A (0.45) CNR2ALDH1A1LMNAHTTKDM4E
SCHEMBL3049374 0.75 ADRA1A (0.49) CNR2CNR1ALDH1A1TSHRADRA1A
SCHEMBL1908225 0.74 SLC16A3 (0.52) CNR2CNR1SLC6A2ALDH1A1LMNA
SCHEMBL8372488 0.73 ALDH1A1 (0.66) KHKALDH1A1L3MBTL1MAPK1RORC
SCHEMBL9283417 0.73 OXER1 (0.45) SLC6A2
SCHEMBL18154916 0.73 NPC1 (0.48) KHKCNR2CNR1ALDH1A1HPGD
SCHEMBL13098456 0.70 CYP1A2 (0.44) CNR2CNR1ALDH1A1LMNAHTT
SCHEMBL25222249 0.70 KHK (0.40) KHKSLC6A2POLBMAPT
SCHEMBL29405144 0.69 CNR2 (0.45) CNR2CNR1ALDH1A1LMNAKDM4E
SCHEMBL25297050 0.69 CNR2 (0.45) CNR2CNR1ALDH1A1LMNAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5393761-A Treatment of nervous system disorders H. LUNDBECK A/S (DK) 1995-02-28 — — US disclosed
EP-0470039-B1 Novel 3-arylindole and 3-arylindazole derivatives LUNDBECK & CO AS H (DK) 1994-12-07 — — EP disclosed
EP-0470039-A2 Novel 3-arylindole and 3-arylindazole derivatives H. LUNDBECK A/S (DK) 1992-02-05 — — EP disclosed
Send feedback